Ryan Nipp to Aged, 80 and over
This is a "connection" page, showing publications Ryan Nipp has written about Aged, 80 and over.
Connection Strength
2.114
-
Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience. Cancer Med. 2021 10; 10(20):7152-7161.
Score: 0.135
-
Associations of baseline patient-reported outcomes with treatment outcomes in advanced gastrointestinal cancer. Cancer. 2021 02 15; 127(4):619-627.
Score: 0.127
-
Functional Impairment, Symptom Burden, and Clinical Outcomes Among Hospitalized Patients With Advanced Cancer. J Natl Compr Canc Netw. 2020 06; 18(6):747-754.
Score: 0.123
-
Pilot Randomized Trial of a Transdisciplinary Geriatric and Palliative Care Intervention for Older Adults With Cancer. J Natl Compr Canc Netw. 2020 05; 18(5):591-598.
Score: 0.123
-
Differential effects of an electronic symptom monitoring intervention based on the age of patients with advanced cancer. Ann Oncol. 2020 01; 31(1):123-130.
Score: 0.120
-
Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer. Ann Oncol. 2019 02 01; 30(2):274-280.
Score: 0.113
-
Patterns and predictors of end-of-life care in older patients with pancreatic cancer. Cancer Med. 2018 12; 7(12):6401-6410.
Score: 0.111
-
Pilot Randomized Trial of a Pharmacy Intervention for Older Adults with Cancer. Oncologist. 2019 02; 24(2):211-218.
Score: 0.110
-
Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care Act. JAMA Oncol. 2018 06 01; 4(6):791-797.
Score: 0.107
-
Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med. 2018 02; 7(2):525-535.
Score: 0.105
-
Predictors of Early Mortality After Surgical Resection of Pancreatic Adenocarcinoma in the Era of Neoadjuvant Treatment. Pancreas. 2017 02; 46(2):183-189.
Score: 0.098
-
Age and Gender Moderate the Impact of Early Palliative Care in Metastatic Non-Small Cell Lung Cancer. Oncologist. 2016 Jan; 21(1):119-26.
Score: 0.090
-
Performance status in elderly patients with acute myeloid leukemia: exploring gene expression signatures of cytokines and chemokines. J Gerontol A Biol Sci Med Sci. 2015 Jun; 70(6):714-21.
Score: 0.076
-
CD38 variation as a prognostic factor in chronic lymphocytic leukemia. Leuk Lymphoma. 2014 Jan; 55(1):191-4.
Score: 0.076
-
National survey of financial burden and experience among patients with cancer and autoimmune disease receiving charitable copay assistance. Cancer. 2025 Jan 15; 131(2):e35721.
Score: 0.042
-
Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2023 05; 23(5):379-384.
Score: 0.037
-
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer. Clin Cancer Res. 2021 10 15; 27(20):5586-5594.
Score: 0.033
-
Caregiver-Oncologist Prognostic Concordance, Caregiver Mastery, and Caregiver Psychological Health and Quality of Life. Oncologist. 2021 04; 26(4):310-317.
Score: 0.032
-
Video-Based Telehealth Visits Decrease With Increasing Age. Am J Gastroenterol. 2021 02 01; 116(2):431-432.
Score: 0.032
-
Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians. Cancer. 2020 08 01; 126(15):3534-3541.
Score: 0.031
-
Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitors. Cancer. 2020 05 15; 126(10):2288-2295.
Score: 0.030
-
Sexual Function, Quality of Life, and Mood After Radiation Therapy in Patients with Anal Cancer. J Gastrointest Cancer. 2020 Mar; 51(1):204-210.
Score: 0.030
-
Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers. Clin Cancer Res. 2020 04 15; 26(8):1877-1885.
Score: 0.030
-
Potentially burdensome end-of-life transitions among nursing home residents with poor-prognosis cancer. Cancer. 2020 03 15; 126(6):1322-1329.
Score: 0.030
-
Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis. Oncologist. 2019 07; 24(7):945-954.
Score: 0.028
-
Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer. J Thorac Oncol. 2019 03; 14(3):547-552.
Score: 0.028
-
Survival Disparities by Race and Ethnicity in Early Esophageal Cancer. Dig Dis Sci. 2018 11; 63(11):2880-2888.
Score: 0.027
-
Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer. Am J Clin Oncol. 2018 07; 41(7):656-661.
Score: 0.027
-
Predictors of Posthospital Transitions of Care in Patients With Advanced Cancer. J Clin Oncol. 2018 01 01; 36(1):76-82.
Score: 0.026
-
Health-related Quality of Life and Functional Outcomes in 5-year Survivors After Pancreaticoduodenectomy. Ann Surg. 2017 10; 266(4):685-692.
Score: 0.026
-
Processes of code status transitions in hospitalized patients with advanced cancer. Cancer. 2017 Dec 15; 123(24):4895-4902.
Score: 0.026
-
Distress is Interdependent in Patients and Caregivers with Newly Diagnosed Incurable Cancers. Ann Behav Med. 2017 Aug; 51(4):519-531.
Score: 0.025
-
Mental and physical health correlates among family caregivers of patients with newly-diagnosed incurable cancer: a hierarchical linear regression analysis. Support Care Cancer. 2017 03; 25(3):965-971.
Score: 0.024
-
Symptom Burden and Performance Status among Community-Dwelling Patients with Serious Illness. J Palliat Med. 2015 Jun; 18(6):542-4.
Score: 0.022
-
One hundred-foot walk test for functional assessment of clinic patients. Am J Med Sci. 2009 Nov; 338(5):361-7.
Score: 0.015